Literature DB >> 11438447

Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

S Signoretti1, M Loda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11438447      PMCID： PMC1850394          DOI： 10.1016/s0002-9440(10)61666-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  36 in total

1.  Immunolocalisation of oestrogen receptor beta in human tissues.

Authors:  A H Taylor; F Al-Azzawi
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

Review 2.  Molecular mechanisms of selective estrogen receptor modulator (SERM) action.

Authors:  M Dutertre; C L Smith
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

Review 3.  Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta.

Authors:  M Pavao; A M Traish
Journal:  Steroids       Date:  2001-01       Impact factor: 2.668

4.  Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Authors:  T A Järvinen; M Pelto-Huikko; K Holli; J Isola
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Authors:  S Signoretti; R Montironi; J Manola; A Altimari; C Tam; G Bubley; S Balk; G Thomas; I Kaplan; L Hlatky; P Hahnfeldt; P Kantoff; M Loda
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

Review 6.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

Authors:  K M Lau; M LaSpina; J Long; S M Ho
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

8.  Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.

Authors:  A Di Cristofano; M De Acetis; A Koff; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

9.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

10.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes.

Authors:  S Dupont; A Krust; A Gansmuller; A Dierich; P Chambon; M Mark
Journal:  Development       Date:  2000-10       Impact factor: 6.868
View more
  15 in total

1.  Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer.

Authors:  Lin Yang; Preethi Ravindranathan; Meera Ramanan; Payal Kapur; Stephen R Hammes; Jer-Tsong Hsieh; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  Opposing action of estrogen receptors alpha and beta on tumor necrosis factor-alpha gene expression and caspase-8-mediated apoptotic effects in HA22T cells.

Authors:  Erh-Jung Huang; Cheng-Chung Wu; Shin-Da Lee; Juen-Hau Chen; Jer-Yuh Liu; Jiunn-Liang Ko; James A Lin; Min-Chi Lu; Li-Mien Chen; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Mol Cell Biochem       Date:  2006-04-22       Impact factor: 3.396

3.  Drug therapies for eradicating high-grade prostatic intraepithelial neoplasia in the prevention of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2005

4.  Estrogen receptor beta as a mitochondrial vulnerability factor.

Authors:  Shao-Hua Yang; Saumyendra N Sarkar; Ran Liu; Evelyn J Perez; Xiaofei Wang; Yi Wen; Liang-Jun Yan; James W Simpkins
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

Review 5.  DHEA metabolism in prostate: For better or worse?

Authors:  Julia T Arnold
Journal:  Mol Cell Endocrinol       Date:  2008-11-01       Impact factor: 4.102

6.  Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

Authors:  Simona Nanni; Valentina Benvenuti; Annalisa Grasselli; Carmen Priolo; Aurora Aiello; Stefania Mattiussi; Claudia Colussi; Vittoria Lirangi; Barbara Illi; Manuela D'Eletto; Anna Maria Cianciulli; Michele Gallucci; Piero De Carli; Steno Sentinelli; Marcella Mottolese; Paolo Carlini; Lidia Strigari; Stephen Finn; Elke Mueller; Giorgio Arcangeli; Carlo Gaetano; Maurizio C Capogrossi; Raffaele Perrone Donnorso; Silvia Bacchetti; Ada Sacchi; Alfredo Pontecorvi; Massimo Loda; Antonella Farsetti
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

Review 7.  STAT3 inhibitors: finding a home in lymphoma and leukemia.

Authors:  Javier Munoz; Navjot Dhillon; Filip Janku; Stephanie S Watowich; David S Hong
Journal:  Oncologist       Date:  2014-04-04

8.  Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

Authors:  Xuegong Zhu; Irwin Leav; Yuet-Kin Leung; Mengchu Wu; Qin Liu; Ying Gao; John E McNeal; Shuk-Mei Ho
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

9.  Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of korean men.

Authors:  Bo Sung Shin; Eu Chang Hwang; Chang Min Im; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Soo Bang Ryu
Journal:  Korean J Urol       Date:  2010-12-21

10.  Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.

Authors:  Young Kwang Chae; Han-Yao Huang; Paul Strickland; Sandra C Hoffman; Kathy Helzlsouer
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.